Kosmos in new Suriname oil search on prospects similar to ExxonMobil’s Longtail and Turbot

Must Read

OilNOW is an online-based Information and Resource Centre

Kosmos Energy is days away from spudding its latest wildcat off Suriname where the US independent kicked up dust at its most recent well earlier this summer.

According to an Upstream report published on Monday, the Dallas-based player will spud the Pontoenoe-1 exploration well on its operated Block 42 abutting the maritime boundary with Guyana in mid-August, it said on Monday.

The well is the first of three wells on independent prospects on the block and will be drilled with the drillship Ensco DS-12.

Pontoenoe-1 is a similar play type to the Turbot and Longtail discoveries unearthed by ExxonMobil and its partners on the prolific Stabroek block off Guyana.

Those finds were two of eight discoveries by the partners, which recently pushed up the estimated discovered recoverable resource base on the block to at least 4 billion barrels of oil equivalent.

The Ensco DS-12 has moved to Block 42 after drilling the Anapai-1A well on Kosmos’ Block 45, where the operator threw up dust.

Kosmos operates Block 42 on 33.33% and is joined by US supermajor Chevron and US independent Hess.

Water depths on the track range between 1800 and 2700 metres, with the block extending over 6176 square kilometres.

In Block 45 it is partnered 50:50 by Chevron. That block sits in water of between 200 and 2000 metres in depth, with the block covering 5126 square kilometres.

Kosmos also revealed on Monday that it has acquired US private equity-backed player Deep Gulf Energy for $1.225 billion.

Kosmos also ran up a loss in the second quarter as costs and expenses outweighed higher revenues.


Partnered Events

Latest News

Sensorion Announces New Positive Secondary Efficacy Endpoints Data From SENS-401 Phase 2a Clinical Trial For The Preservation Of Residual Hearing Loss

MONTPELLIER, France--(BUSINESS WIRE)--Regulatory News: Sensorion (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel...

More Articles Like This